Evidence for Persistent Expression of OX2 as a Necessary Component of Prolonged Renal Allograft Survival Following Portal Vein Immunization

By Gorczynski R.M.   Chen Z.   Kai Y.   Lei J.  

Clinical Immunology, Vol. 97, Iss. 1, 2000-10 ,pp. : 69-78

Academic Press

Access to resources Recommend Favorite

Synergy in Induction of Increased Renal Allograft Survival after Portal Vein Infusion of Dendritic Cells Transduced to Express TGFβ and IL-10, along with Administration of CHO Cells Expressing the Regulatory Molecule OX-2

By Gorczynski R.M.   Bransom J.   Cattral M.   Huang X.   Lei J.   Xiaorong L.   Min W.P.   Wan Y.   Gauldie J.  

Clinical Immunology, Vol. 95, Iss. 3, 2000-06 ,pp. : 182-189

Academic Press

Access to resources Recommend Favorite

Can donor-specific transfusion via the portal vein under activated Kupffer cells enhance the beneficial effect of portal venous tolerance for rat small intestinal transplantation?

By Yamamoto S.   Sato Y.   Suda T.   Kurosaki I.   Okamoto H.   Sakai Y.   Hatakeyama K.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 2485-2485

Elsevier

Access to resources Recommend Favorite

TCR + , Type-2 Cytokine Produced by Hybridoma Cells Produced in Mice Given Portal Vein Pretransplant Immunization and Allogeneic Grafts Can Increase Graft Survival on Adoptive Transfer

By Gorczynski R.   Chen Z.   Levy G.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 865-866

Elsevier

Access to resources Recommend Favorite

Manipulation of xenogeneic skin and/or renal graft survival in the rat-mouse concordant combination by portal vein pretransplant transfusion

By Gorczynski R.   Fu X.-M.   Chung S.   Sullivan B.   Chen Z.  

Transplant Immunology, Vol. 3, Iss. 4, 1995-12 ,pp. : 321-329

Elsevier

Access to resources Recommend Favorite